Lactate produced by tumor cells increases the susceptibility of tumor-specific cytotoxic CD8+ T lymphocytes to activation-induced cell death via NF-κB inactivation, and blocking lactate production can overcome tumor resistance to immunotherapy and improve therapeutic effects (Liu et al., 2023). This evidence concerns the gene CD8A and neoplasm.